| RA-no ILD (n = 135) | RA-indeterminate ILD (n = 107) | RA-mild ILD (n = 91) | RA-advanced ILD (n = 24) | RA-ILD (RA-mild ILD + RA-advanced ILD) (n = 115) | |
---|---|---|---|---|---|---|
Demographic features | Â | Â | Â | Â | Â | |
Age(years) | 54.94 ± 10.92 | 59.19 ± 9.09** | 61.97 ± 8.80*** | 64.38 ± 11.97*** | 62.47 ± 9.54*** | |
Male, n(%) | 33(24.44) | 32(29.91) | 20(21.98) | 14(58.33)** | 34(29.57) | |
BMI(kg/m2) | 21.77 ± 3.41 | 21.96 ± 3.06 | 23.51 ± 3.92** | 22.48 ± 3.57 | 23.30 ± 3.86** | |
Current/ever smoking, n(%) | 16(11.85) | 17(15.89) | 12(13.19) | 10(41.67)** | 22(19.13) | |
RA associated clinical features | Â | Â | Â | Â | Â | |
Duration of RA(years) | 7.00(2.00,11.00) | 7.00(1.00,15.00) | 6.00(1.00,13.00) | 5.00(2.00,10.00) | 5.00(2.00,11.00) | |
Morning stiffness, n(%) | 99(73.33) | 80(74.77) | 63(69.23) | 16(66.67) | 79(68.70) | |
Joint deformity, n(%) | 50(37.04) | 43(40.19) | 31(34.07) | 8(33.33) | 39(33.91) | |
RF, IU/ml | 82.80(18.00,268.00) | 105.00(29.80,429.00) | 125.00(22.40,491.00) | 437.50(111.00,1077.25)*** | 144.00(23.70,541.00)* | |
Anti-CCP, RU/ml | 83.60(16.70,200.00) | 79.80(34.10,200.00) | 81.90(12.60,200.00) | 184.00(48.55,200.00) | 99.10(18.70,200.00) | |
DAS28(CRP) | 4.11 ± 1.50 | 4.21 ± 1.73 | 4.14 ± 1.64 | 3.73 ± 1.45 | 4.06 ± 1.61 | |
DAS28(ESR) | 4.67 ± 1.52 | 4.87 ± 1.72 | 4.78 ± 1.66 | 4.66 ± 1.46 | 4.76 ± 1.62 | |
Respiratory manifestations | Â | Â | Â | Â | Â | |
Cough, n(%) | 0(0.00) | 2(1.87) | 5(5.49)* | 15(62.50)*** | 20(17.39)*** | |
Dyspnea, n(%) | 1(0.74) | 1(0.93) | 3(3.30) | 14(58.33)*** | 17(14.78)*** | |
Velcro rale, n(%) | 0(0.00) | 0(0.00) | 2(2.20) | 13(54.17)*** | 15(13.04)*** | |
Pulmonary function test | Â | Â | Â | Â | Â | |
FVC%pred | 92.00 ± 7.07 | 86.11 ± 9.18 | 81.33 ± 13.22 | 77.67 ± 20.05 | 80.11 ± 15.31 | |
DlCO%pred | 97.00 ± 18.39 | 74.22 ± 31.29 | 59.50 ± 18.22* | 55.83 ± 18.08* | 58.28 ± 17.72* | |
CT pattern | Â | Â | Â | Â | Â | |
UIP | Â | Â | Â | 16(66.67) | Â | |
NSIP | Â | Â | Â | 8(33.33) | Â | |
Inflammatory markers | Â | Â | Â | Â | Â | |
CRP, mg/l | 15.30(3.49,43.30) | 13.30(4.07,39.80) | 15.20(4.93,57.00) | 9.29(4.04,32.08) | 14.50(4.48,46.90) | |
ESR, mm/h | 40.00(19.00,74.00) | 40.00(22.00,65.00) | 44.00(25.00,81.00) | 55.50(38.00,74.25) | 45.00(26.00,80.00) | |
Pulmonary arterial pressure, mmHg | 27.60 ± 5.30 | 28.91 ± 5.25 | 30.01 ± 6.81 | 33.10 ± 5.24* | 30.64 ± 6.59* | |
Comorbidities | Â | Â | Â | Â | Â | |
Hypertension, n(%) | 26(19.26) | 25(23.36) | 27(29.67) | 4(16.67) | 31(26.96) | |
Diabetes, n(%) | 11(8.15) | 16(14.95) | 12(13.19) | 3(12.50) | 15(13.04) | |
Osteoporosis, n(%) | 48(35.56) | 42(39.25) | 53(58.24)** | 12(50.00) | 65(56.52)** | |
Osteopenia, n(%) | 29(21.48) | 28(26.17) | 17(18.68) | 6(25.00) | 23(20.00) | |
Fragility fracture, n(%) | 5(3.70) | 7(6.54) | 13(14.29)** | 3(12.50) | 16(13.91)** | |
Joint replacement, n(%) | 6(4.44) | 13(12.15) | 4(4.40) | 1(4.17) | 5(4.35) | |
Medication | Â | Â | Â | Â | Â | |
Corticosteroid, n(%) | 45(33.33) | 31(28.97) | 32(35.16) | 13(54.17) | 45(39.13) | |
Immunosuppressant, n(%) | 63(46.67) | 49(45.79) | 40(43.96) | 16(66.67) | 56(48.70) |